Daiwa Securities Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
Daiwa Securities Group's SGMO Position: Q4 2023 in Review
Daiwa Securities Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2023, closing a stake of 498 shares.
Daiwa Securities Group first reported a position in SGMO in Q1 2018 and held it in 23 quarters. The position peaked at $9K in Q1 2018. 130 funds tracked by Wall St. Rank hold SGMO as of Q4 2023.
- Daiwa Securities Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2023 after selling out during the quarter.
- Daiwa Securities Group sold 498 SANGAMO THERAPEUTICS INC shares in Q4 2023.
- Daiwa Securities Group first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 23 quarters.
- Daiwa Securities Group's SANGAMO THERAPEUTICS INC position peaked at $9K in Q1 2018.
- 130 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2023.
Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.